Month: April 2021

STAT+: Brazilian senate votes to suspend patents in bid to widen access to Covid-19 vaccines

After a year of politicking, the Brazilian senate passed a bill that would permit the government to temporarily suspend any and all patents for medical products that could be used to fight Covid-19, as well as any future public health emergency declared by Brazilian authorities or the World Health Organization. Any license would be valid […]

STAT+: U.S. government has invested $6 billion in Moderna’s Covid-19 vaccine

The federal government has now invested about $6 billion in the Covid-19 vaccine from Moderna, the Cambridge, Mass., biotech that few outside the scientific and investment worlds had heard of a couple of years ago. Moderna said in a filing with the Securities and Exchange Commission on Wednesday that under a change in its government […]

HHS to prioritize newborn screening programs’ pipette tip orders

Programs that screen newborns for potentially deadline genetic conditions will now have higher priority when ordering pipette tips — a critical laboratory supply that is in shortage. STAT highlighted the pipette tip shortage, which is affecting researchers across the country, on Wednesday. Read the rest…

STAT+: Up and down the ladder: The latest comings and goings

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular […]

STAT+: Pharmalittle: Wyden goes back to the drawing board on drug pricing; Emergent undergoes an executive shake-up

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is ambitious when measured by our usual standards. As the designated Pharmalot groundskeeper, we plan to beautify the grounds. We also hope to […]

Virologist Angela Rasmussen on the controversy surrounding Russia’s Sputnik V Covid-19 vaccine

By all accounts, the Covid-19 vaccine developed by Russia’s Gamaleya Institute, called Sputnik V, has looked really good. In a study published in The Lancet in February, the vaccine’s efficacy was 91.6%, putting it among the most effective vaccines for this pandemic in the world. The technology used for Sputnik V is similar to the […]

STAT+: Top Senate Democrat heads back to drawing board on drug pricing

WASHINGTON — A powerful Democratic committee chair is starting to work on a new drug pricing package, rather than advancing an existing bill — an onerous effort, but one that may be Democrats’ best hope for substantive action this Congress. Senate Finance Committee Chair Ron Wyden (D-Ore.), a longtime advocate of drug pricing reform, said […]

Scroll to top